Citius Oncology annual return on equity
2022
2022
2023
2023
2024
2025
Citius Oncology Return on Equity (ROE) Growth & History (CTOR)
Citius Oncology's return on equity was −54.42% for fiscal 2025.
View full Citius Oncology company overviewCitius Oncology annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-09-30 | −54.42% | +7.00 pp |
| 2024 | 2024-09-30 | −61.42% | +36.70 pp |
| 2023 · Dec 31 | 2023-12-31 | 10.03% | +7.95 pp |
| 2023 · Sep 30 | 2023-09-30 | −98.12% | −68.15 pp |
| 2022 | 2022-12-31 | 2.08% | — |
| 2022 | 2022-09-30 | −29.97% | — |
Citius Oncology quarterly return on equity
Q1.23
Q2.23
Q4.23
Q4.23
Q1.24
Q2.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q3 2026 | 2026-06-30 | −23.59% | −7.81 pp |
| Q2 2026 | 2026-03-31 | −56.81% | −36.70 pp |
| Q1 2026 | 2025-12-31 | −10.72% | +4.52 pp |
| Q4 2025 | 2025-09-30 | −12.93% | +8.64 pp |
| Q3 2025 | 2025-06-30 | −15.78% | +10.10 pp |
| Q2 2025 | 2025-03-31 | −20.11% | +2.61 pp |
| Q1 2025 | 2024-12-31 | −15.23% | +4.36 pp |
| Q4 2024 | 2024-09-30 | −21.57% | −22.81 pp |
| Q2 2024 | 2024-06-30 | −25.88% | −655.99 pp |
| Q1 2024 | 2024-03-31 | −22.72% | −247.99 pp |
| Q4 2023 | 2023-12-31 | −19.59% | — |
| Q4 2023 · Sep 30 | 2023-09-30 | 1.24% | — |
| Q2 2023 | 2023-06-30 | 630.10% | — |
| Q1 2023 | 2023-03-31 | 225.27% | — |
Citius Oncology return on equity trends
Between the periods ended 2022-09-30 and 2025-09-30, Citius Oncology's return on equity decreased from −29.97% to −54.42%, a change of −24.45 percentage points. The latest reported quarter, Q3 2026, shows −23.59%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Citius Oncology source filings ↗